Facing Our Risk of Cancer Empowered (FORCE), the nation's only nonprofit organization dedicated to families with hereditary breast and ovarian cancer (HBOC), is celebrating National Hereditary Breast and Ovarian Cancer Week and National Previvor Day to create awareness and recognize those affected by a genetic predisposition to these cancers.
A new study has confirmed that e-cigarettes are doing more harm than good when it comes to helping cancer patients quit smoking.
To address the question of whether axillary dissection is necessary in older women, researchers in Milan, Italy recruited 238 women aged 65-80 years with cT1cN0 breast cancer and randomized them to receive conservative surgery with or without axillary node dissection.
More than one-third of patients with breast or ovarian cancer or a family history of those diseases who also saw a genetic counselor did not pursue genetic testing for BRCA 1 or BRCA 2 mutations
Dr. Drew Pinsky's personal battle with prostate cancer inspires him to join forces with PCF
New patient-reported data presented at the 2014 ASTRO Annual Meeting has shown that Manuka honey is not more effective than standard medical care for the treatment of esophagitis pain during radiation therapy.
A new analysis of the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial presented at the ASTRO 56th Annual Meeting offers substantial evidence that treatment with radiation therapy does not increase the incidence of lymphedema in patients with node-negative breast cancer.
A retired dentist and avid cyclist, Neil Dicker of Orefield, Pennsylvania is also a dedicated advocate for individuals affected by cutaneous lymphoma. In this video, Neil shares his inspiring story of living with the disease.
Does Medicare coverage for patients with cancer match up to what they actually want covered?
With the use of MRI imaging to restrict doses to erectile tissues, nearly half of men treated with external beam radiation therapy (EBRT) for prostate cancer were able to be sexually active without aids or medications 5 years later, and nearly 80% could be sexually active if such support was an option
A new study from Thomas Jefferson University suggests that observation may not be right for all patients with early stage prostate cancer.
That support is provided by matching people diagnosed with cancer and/or family members with trained volunteers who have themselves undergone and recovered from a similar cancer experience.
Radiotherapy is equally as effective in the palliation of dysphagia (difficulty swallowing) as chemoradiotherapy for patients with advanced esophageal cancer
In an "Art of Oncology" column in the Journal of Clinical Oncology, Nandita Khera, MBBS, MPH from the Mayo Clinic in Phoenix, AZ, proposes that financial toxicity is an important effect of cancer treatment that can be as devastating as other adverse medical events.
A study conducted by researchers at the Mayo Clinic has found that family conflicts and other nonmedical problems may raise their risk of complications following cancer surgery.
Please join us in Washington, DC, on September 20th for Cocktails for a Cure!
Show some heart! Register or donate to support the 2014 National Race to End Women's Cancer, Sunday, November 2 at the Freedom Plaza in Washington, DC.
The FDA has expanded the approval for the androgen receptor inhibitor enzalutamide (Xtandi) to include the treatment of men with chemotherapy-naive mCRPC.
New research suggests that men who aren't well educated about their prostate cancer have a much more difficult time making treatment decisions.
Underscoring the need to raise awareness among oncology nurses of the importance of adhering to safety precautions when administering chemotherapy and other hazardous drugs, the NIOSH has awarded a $2.3 million research grant to identify exposure risks and promote strategies to combat them.
When depression is identified, it often goes untreated.
A new study is shedding light on the need for cancer centers to invest more in palliative care services, adequate rooms for dying patients, staff training in end-of-life care, and advanced care–planning standards.
Women who received the hormone suppressor goserelin (Zoladex) along with their chemotherapy were significantly less likely to develop premature ovarian failure and were more likely to have successful pregnancies, than women who received chemotherapy alone, according to findings from the federally funded phase III S0230/POEMS clinical trial.
About 5% to 10% of breast cancers are thought to be hereditary, caused by abnormal genes passed from parent to child.
The FDA has approved pembrolizumab (Keytruda) for the treatment of advanced melanoma, making it the first PD-1 inhibitor to receive approval in the United States and marking yet another milestone breakthrough for patients who once had little hope of surviving this disease.
Endometrial cancer is the most common gynecologic cancer and the fourth most common cancer.
Cutaneous lymphomas are a distinct subset of non-Hodgkin's lymphoma. They are cancers of lymphocytes (white blood cells) that primarily involve the skin.
One of the first studies to prospectively examine women's breast surgery preferences has revealed that newly diagnosed women with breast cancer who decide to undergo contralateral prophylactic mastectomy (CPM) aren't relying on evidence-based information, highlighting the need for interdisciplinary patient education and communication.
With more and more data supporting the association between actress Angelina Jolie's double mastectomy and an increase in the amount of patients seeking genetic testing, the attention is on genetic counselors to improve their intake model to more efficiently handle the increased demand.
The event addresses the management of symptoms and complications of chronic pancreatitis.
